GeneType is a subsidiary of Genetic Technologies who is a leader in the development and commercialization of genetic risk assessment technology. Our tests predict an individual’s risk of developing chronic disease.
To improve health outcomes for people around the world by providing individuals and their healthcare providers with the risk assessment tools to develop personalized health management plans for early detection and treatment of chronic disease.
To continually strive to maintain our standing as a global leader in genomics by investing in our own research capabilities and by forming partnerships with experts from world class organizations.
Our CLIA (Clinical Laboratory Improvement Amendments of 1988) certified and ISO (International Organization for Standardization) accredited laboratory operates out of Melbourne, Australia and provides testing to all 50 states in the US, as well as Australia and around the world.
CLIA ID Number: 99D2023356
Safeguarding the privacy and security of personal health information is among our most important responsibilities.
Click here for our Privacy Policy
